INDEMNIFICATION AGREEMENTIndemnification Agreement • March 3rd, 2021 • Forian Inc. • Services-computer processing & data preparation • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of March 2, 2021 between Forian Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 2nd, 2021 • Forian Inc. • Services-computer processing & data preparation • New York
This EMPLOYMENT AGREEMENT (this “Agreement”) is made as of September 2, 2021, by and between Forian Inc., a Delaware corporation (the “Company”), and Michael Vesey (“Executive”).
License AgreementLicense Agreement • February 1st, 2021 • Forian Inc. • Services-computer processing & data preparation • Delaware
THIS LICENSE AGREEMENT (this “Agreement”) is entered into as of June 30, 2019 (“Effective Date”) by and between DR/Decision Resources, LLC (“Company”), a Delaware corporation, and Medical Outcomes Research Analytics, LLC (“Client”), a Delaware limited liability company. Company and Client are hereinafter sometimes referred to individually as a “Party” and together as the “Parties”.
VOTING AND SUPPORT AGREEMENTVoting and Support Agreement • December 31st, 2020 • Forian Inc. • Services-computer processing & data preparation • Delaware
This VOTING AND SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of October 16, 2020 by and among Forian Inc., a Delaware corporation (“Parent”), on the one hand, and the undersigned securityholder (a “Securityholder”) of Helix Technologies, Inc., a Delaware corporation (the “Company”), on the other hand.
EQUITY INTEREST CONTRIBUTION AGREEMENTEquity Interest Contribution Agreement • March 3rd, 2021 • Forian Inc. • Services-computer processing & data preparation • Delaware
This EQUITY INTEREST CONTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of March 2, 2021 by and among Forian Inc., a Delaware corporation (“Parent”), Medical Outcomes Research Analytics, LLC, a Delaware limited liability company (“MOR”), and the undersigned equityholders of MOR (collectively, the “Equityholders” and each individually, an “Equityholder”).
LICENSE AGREEMENTLicense Agreement • February 13th, 2023 • Forian Inc. • Services-computer processing & data preparation • Delaware
THIS LICENSE AGREEMENT (this “Agreement”), dated as of February 10, 2023 (the “Effective Date”), is made and entered into by and among Forian Inc., a Delaware corporation (“Forian”) and Helix Technologies, Inc., a Delaware Corporation (“Seller” and together with Forian, the “Licensees”), each for itself and for the benefit of their respective Affiliates, collectively as licensees, on the one hand, and each of BT Assets Group, Inc., a Delaware corporation (“Buyer”), and Bio-Tech Medical Software, Inc., a Florida corporation (the “Company”), each for itself and on behalf of their respective Affiliates, collectively as licensors, on the other hand. Buyer and the Company are referred to in this Agreement each as a “Licensor” and collectively as the “Licensors”. Forian, Seller, Buyer and the Company are collectively referred to in this Agreement each as a “Party” and collectively as the “Parties.”
AMENDMENT 2Second Amendment • December 22nd, 2023 • Forian Inc. • Services-computer processing & data preparation
This SECOND Amendment (this “Amendment 2”) is entered into effective as of December 20, 2023 (the “Amendment 2 Effective Date”), by and between [***] (“Company”) and Medical Outcomes Research Analytics, LLC (“Client”) and amends that certain License Agreement, dated June 30, 2019, as amended by Amendment 1 dated April 9, 2020 (the “Agreement”), between the Company and Client. Capitalized terms used but not otherwise defined in this Amendment 2 with have the meanings given to them in the Agreement.
AMENDMENT TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • December 31st, 2020 • Forian Inc. • Services-computer processing & data preparation
This AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this “Amendment”), dated as of December 30, 2020, among Helix Technologies, Inc., a Delaware corporation (the “Company”), Forian Inc., a Delaware corporation (“Parent”), DNA Merger Sub Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Medical Outcomes Research Analytics, LLC, a Delaware limited liability company (“MOR”).
STOCK PURCHASE AGREEMENT BY AND AMONG BIO-TECH MEDICAL SOFTWARE, INC., HELIX TECHNOLOGIES, INC. AND BT ASSETS GROUP, INC. DATED AS OF FEBRUARY 10, 2023Stock Purchase Agreement • February 13th, 2023 • Forian Inc. • Services-computer processing & data preparation • Delaware
THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of February 10, 2023, by and among BT Assets Group, Inc., a Delaware corporation (“Buyer”), on the one hand, and each of Helix Technologies, Inc., a Delaware corporation (“Seller”), and Bio-Tech Medical Software, Inc. (d/b/a BioTrack), a Florida corporation and a wholly owned subsidiary of Seller (the “Company”), on the other hand.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 13th, 2021 • Forian Inc. • Services-computer processing & data preparation • Delaware
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of April 12, 2021, is made by and among Forian Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • February 9th, 2021 • Forian Inc. • Services-computer processing & data preparation
This AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF MERGER (this “Amendment”), dated as of February 9, 2021, among Helix Technologies, Inc., a Delaware corporation (the “Company”), Forian Inc., a Delaware corporation (“Parent”), DNA Merger Sub Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Medical Outcomes Research Analytics, LLC, a Delaware limited liability company (“MOR”).
Re: Transition and Release AgreementContribution Agreement • September 2nd, 2021 • Forian Inc. • Services-computer processing & data preparation
With our sincere thanks for your service, this letter (this “Agreement”) sets forth the terms of our mutual agreement regarding your transition and departure from the employ of Forian Inc. (including its subsidiaries, the “Company”) and your service as our Chief Financial Officer.
NOTE PURCHASE AGREEMENTNote Purchase Agreement • September 2nd, 2021 • Forian Inc. • Services-computer processing & data preparation • Delaware
THIS NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of September 1, 2021, is made by and among Forian Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
Re: Separation and Release AgreementForian Inc. • February 13th, 2023 • Services-computer processing & data preparation • Pennsylvania
With our sincere thanks for your service to Forian Inc. (together with its subsidiary and affiliated companies, collectively the “Company”), this letter agreement (the “Agreement”) sets forth the terms and conditions of our mutual agreement regarding the separation of your employment as the Chief Executive Officer and President of the Company consistent with your rights and obligations as set forth in that certain Employment Agreement, dated as of October 16, 2019, by and between you and the Company (through its subsidiary, Medical Outcomes Research Analytics, LLC)(the “Employment Agreement”). Capitalized terms used and not defined herein shall have the meanings given to such terms in that certain Employment Agreement.
FORIAN INC. SPECIAL ADVISOR AGREEMENTSpecial Advisor Agreement • March 31st, 2021 • Forian Inc. • Services-computer processing & data preparation • Pennsylvania
THIS SPECIAL ADVISOR AGREEMENT (“Agreement”) is made and entered into as of January 26, 2021 by and between Forian Inc. (the “Company”) and Scott Ogur (“Advisor”) (the Company and Advisor collectively referred to as the “Parties”, and the Company, together with each such subsidiary and/or parent including those formed after the Effective Date, collectively referred to as the “Company Group”).
